Skip to main content
. 2024 Jul 17;15:1401008. doi: 10.3389/fpsyt.2024.1401008

Table 4.

Differences in outcomes from baseline to week 1 and week 3 between patients receiving real and sham rTMS.

Sham rTMS Active rTMS
Baseline W1 W3 Baseline W1 W3
Usual pain intensity 6.5 (1.5) 6.5 (1.7) 6.7 (1.4) 6.5 (1.2) 6.4 (1.7) 6.2 (2.2)
Multitasking test – MTTTIC 11.8 (11.8) 10.1 (7.7) 10.1 (12.8) 16.0 (17.2) 13.5 (12.2) 12.0 (13.4)
Paired Associates Learning
 PALTEA8 17.8 (8.8) 16.6 (10.6) 17.4 (10.4) 16.8 (10.8) 16.4 (11.1) 15.9 (8.4)
 PALTEA28 28.3 (17.7) 26.6 (18.4) 28.7 (19.2) 26.1 (16.1) 25.1 (17.4) 24.7 (13.5)
Stop Signal Task – SSTSSRT 238.8 (50.9) 235.5 (53.2) 227.6 (60.1) 256.2 (59.4) 233.9 (44.2) 231.2 (49.3)
Spatial working memory
 SWMS 7.2 (2.8) 6.3 (2.6) 6.6 (2.8) 8.3 (3.2) 7.6 (2.6) 6.7 (2.5)
 SWMBE8 9.3 (7.5) 5.5 (6.0) 6.3 (5.9) 9.4 (6.1) 7.4 (4.6) 6.1 (5.9)
Composite score -0.03 (0.8) -0.06 (0.7) 0.02 (0.8) 0.03 (0.6) 0.07 (0.6) -0.02 (0.7)

Results are expressed as mean (SD). Valid percentages displayed (missing data excluded). No significant interactions between treatment and time were found for any of the outcome measures (p < 0.05). Lower values indicate higher performance for all measures.